5Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease, J Am Coil Cardiol, 2014, 63: 2438-2488.
6Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coil Cardiol, 2008, 52: e143-e263.
7Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J, 2012, 33: 2451-2496.
8Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two- dimensional and Doppler echocardiography. J Am Soc Echocardiogr, 2003, 16: 777-802.
9Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio- Thoracic Surgery (EACTS). Eur J Cardiothorac Surg, 2012, 42: S 1-44.
10Vahaniana A, Iung B. The new ESC/EACTS Guidelines on the management of valvular heart disease. Arch Cardiovasc Dis, 2012, 105: 465-467.
